Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Ascentage Pharma Received US$100 Million Option Payment from Takeda 2024-07-04 08:28
Datasea Announces Closing of $2.25 Million Registered Direct Offering 2024-07-04 04:30
AXA launches CareForAll Hospital Cash Plan to foster proactive care and alleviate financial concerns associated with hospitalisation 2024-07-03 16:52
/C O R R E C T I O N -- Menarini Silicon Biosystems/ 2024-07-03 03:24
Bloomage Ranks on World Brand Lab's China 500 Most Valuable Brands List 2024-07-02 21:00
Health In Tech, Adena Health, and OSU Health Plan Solutions Partner to Bring Affordable Level-Funded Health Plans to Ohio Employers 2024-07-02 20:30
Datasea Announces Pricing of $2.25 Million Registered Direct Offering 2024-07-02 20:30
Angel Yeast Partners with ffit8 to Launch Nougat Protein Bar and Protein Nougat Snack 2024-07-02 20:00
Pulnovo Medical Announces First Enrollment in Portugal for Global Clinical Study of PADN Technology in Treating Pulmonary Hypertension Associated with Left Heart Disease 2024-07-02 19:10
FXGT.com Partners with Great Heart Charity to Empower Underprivileged Communities 2024-07-02 16:42
Zepp Health Introduces Zepp OS 4: Redefining Wearable Intelligence by Integrating OpenAI's GPT-4o into its Amazfit Smartwatches 2024-07-02 16:00
Saudi Arabia to host the first-ever International Conjoined Twins Conference on 24-25 November 2024: KSrelief 2024-07-02 15:46
Clarivate Identifies Six Breakthrough MedTech Trends in 2024 Set to Unlock New Industry Opportunities 2024-07-02 15:00
PharmAbcine's Phase 1 Clinical Trial of PMC-403 for Neovascular Age-related Macular Degeneration Advances to Both Single-dose of 4mg and Multiple-dose of 3mg 2024-07-02 11:02
Noul Co., Ltd. Releases 2023-2024 Sustainability Report 2024-07-02 10:52
HiRO acquires CRO DeltaMed Solutions, continues to expand cross-border operations in the US 2024-07-02 10:00
Cicada Innovations calls for systems approach to 'turbocharge' Future Made in Australia act, announces Tech23 cohort 2024-07-02 08:06
Altos Biologics Files for Approval of Aflibercept Biosimilar 2024-07-02 08:00
Innovent Announces Oral Presentation at the ESMO Gastrointestinal Cancers Congress 2024 on Latest Clinical Data of Anti-CLDN18.2 ADC (IBI343) in Patients with Advanced Gastric/Gastroesophageal Junction Adenocarcinoma 2024-07-02 08:00
Bridgewest Perth Pharma gains strategic edge with noted Australian Executive John Van Der Wielen on Board 2024-07-02 07:00
1 66 67 68 69 70 1596